These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
213 related items for PubMed ID: 8887044
21. Combination of cyst fluid CEA and CA 125 is an accurate diagnostic tool for differentiating mucinous cystic neoplasms from intraductal papillary mucinous neoplasms. Nagashio Y, Hijioka S, Mizuno N, Hara K, Imaoka H, Bhatia V, Niwa Y, Tajika M, Tanaka T, Ishihara M, Shimizu Y, Hosoda W, Yatabe Y, Yamao K. Pancreatology; 2014; 14(6):503-9. PubMed ID: 25458668 [Abstract] [Full Text] [Related]
22. Hepatobiliary mucinous cystadenoma and cystadenocarcinoma: report of six cases and review of the literature. Yu J, Wang Y, Yu X, Liang P. Hepatogastroenterology; 2010; 57(99-100):451-5. PubMed ID: 20698207 [Abstract] [Full Text] [Related]
23. The importance of cyst fluid analysis for differentiation of pancreatic cyst. Inan M, Besim H, Serhat H, Büyük S. Acta Chir Belg; 2008; 108(3):350-3. PubMed ID: 18710114 [Abstract] [Full Text] [Related]
28. Biliary mucinous cystic neoplasm mimicking a hydatid cyst: a case report and literature review. Tholomier C, Wang Y, Aleynikova O, Vanounou T, Pelletier JS. BMC Gastroenterol; 2019 Jun 24; 19(1):103. PubMed ID: 31234803 [Abstract] [Full Text] [Related]
30. Role of tumor markers in the diagnosis of cystic and intraductal neoplasms. Hammel P. Gastrointest Endosc Clin N Am; 2002 Oct 24; 12(4):791-801. PubMed ID: 12607788 [Abstract] [Full Text] [Related]
31. Hepatobiliary cystadenocarcinoma with cystadenoma elements of the gall bladder in an old man. Terada T, Takeuchi T, Taniguchi M. Pathol Int; 2003 Nov 24; 53(11):790-5. PubMed ID: 14629305 [Abstract] [Full Text] [Related]
33. Role of cystic fluid in diagnosis of the pancreatic cystadenoma and cystadenocarcinoma. Wu H, Yan LN, Cheng NS, Zhang YG, Ker CG. Hepatogastroenterology; 2007 Nov 24; 54(79):1915-8. PubMed ID: 18251127 [Abstract] [Full Text] [Related]
37. Carbohydrate 19-9 antigen as a marker of non-malignant hepatocytic ductular transformation in patients with acute liver failure. A comparison with alpha-fetoprotein and carcinoembryonic antigen. Halme L, Kärkkäinen P, Isoniemi H, Mäkisalo H, von Bogulawski K, Höckerstedt K. Scand J Gastroenterol; 1999 Apr 24; 34(4):426-31. PubMed ID: 10365905 [Abstract] [Full Text] [Related]
38. Cyst fluid analysis to diagnose pancreatic cystic lesions: an as yet unfulfilled promise. Pelaez-Luna M, Chari ST. Gastroenterology; 2006 Mar 24; 130(3):1007-9; discussion 1009. PubMed ID: 16530543 [No Abstract] [Full Text] [Related]
39. Diagnosis and treatment of hepatic cysts. Usefulness of intracystic tumor markers (CEA and CA 19.9.). Polette D, Mils K, López-Domínguez F, Barrios O, Leiva D, Puig I, Ramos E, Lladó L. Cir Esp (Engl Ed); 2024 Jan 24; 102(1):19-24. PubMed ID: 37980963 [Abstract] [Full Text] [Related]